- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00822510
Telephone Counseling: Men With Prostate Cancer & Partners
Telephone Counseling With Men With Prostate Cancer and Partners
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Eligibility Criteria for men: receiving treatment for prostate cancer,over 21 years of age, English speaking, have access to and ability to talk on the phone and have a partner willing to participate in the study. Participants can live anywhere in the United States because the intervention is telephone delivered.
Partners can be anyone the man selects (friend or relative) who is over 21 years of age, English speaking and has access to or ability to speak on the phone.
Men and their partners will be assigned to one of two groups. Each survivor will receive 8 telephone calls over an 8-week period for about 30 minutes each. Each partner will receive 4 telephone calls every other week for about 30 minutes each. We will ask everyone to complete a baseline assessment over the telephone, after the 8 weeks, and then again about 8 weeks after the second assessment.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- University of Arizona
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Receiving treatment for prostate cancer
- Over 21 years
- Access to and ability to talk on the phone
- Speaks English and has a partner to participate with him.
- Partners are anyone who the man chooses (friend or relative) who is over 21 years, English speaking and has access and ability to talk on the phone.
Exclusion Criteria:
- under 21 years
- Does not speak English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telephone Interpersonal Counseling
Telephone delivered interpersonal counseling support intervention.
Intervention was for 8 weeks.
Participants were called on the telephone each week for about 30 minutes.
|
Telephone delivered 8 week education and counseling intervention based on interpersonal psychotherapy.
|
Active Comparator: Telephone delivered education only
Telephone delivered education only.
Educational topics included prostate cancer health, side effects, physical activity, diet.
Participants were called on the telephone each week for about 30 minutes.
|
Telephone delivered 8 week educational intervention on prostate cancer health, side effects, physical activity, diet, smoking cessation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Center for Epidemiological Studies-Depression Scale
Time Frame: 3 points in time, baseline, T2=T1+8 weeks, T3=T2 plus 8 weeks
|
Depression was measured by the 20-item Center for Epidemiological Studies-Depression (CES-D) scale, Range is 0-60.
Scores are added together with higher score greater depression.
|
3 points in time, baseline, T2=T1+8 weeks, T3=T2 plus 8 weeks
|
Perceived Stress
Time Frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Perceived stress scale is a 10-item scale with a range of 0-40.
Higher scores indicate more stress.
|
3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Positive Affect
Time Frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Positive and Negative Affect Scale is a 20 item scale that measures positive and negative affect subscales.
Scores range from 10-50 on each subscale with higher score indicating more positive affect.
|
3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Negative Affect
Time Frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Positive and Negative Affect Scale is a 20 item scale that measures positive and negative affect subscales.
Scores range from 10-50 on each subscale with higher score indicating more positive affect.
|
3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Multidimensional Fatigue Inventory
Time Frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Measure of physical well-being, specifically fatigue, using the Multidimensional Fatigue Scale.
Scores range from 0-80 with higher scores indicative of more fatigue.
|
3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Social Well Being
Time Frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Measures social well-being using the 9 item Social Well-being scale, ranging from 9-90.
Higher score indicates increased social well-being.
|
3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Spiritual Well Being
Time Frame: 3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Measures if spiritual beliefs using a 7-item scale that ranges from 7-70.
Higher score equals greater spiritual wellbeing.
|
3 points in time, baseline, second assess (T1-8week), 3rd assessment (T2+8 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Terry Badger, PhD, RN, University of Arizona College of Nursing
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 04-0376-02
- R21CA113409 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Ryan Kohlbrenner, MDRadiological Society of North AmericaCompletedProstate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage...United States
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate...United States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on Telephone Interpersonal Counseling
-
University of ArizonaNational Cancer Institute (NCI)Completed
-
University of ArizonaNational Cancer Institute (NCI)RecruitingBreast Cancer | Lung Cancer | Skin Cancer | Colon Cancer | Rectum CancerUnited States
-
University of ArizonaAmerican Cancer Society, Inc.RecruitingCancer | Psychological Distress | Informal Caregivers | Cancer SurvivorsUnited States
-
Istanbul University-CerrahpasaCompleted
-
Hospital District of Helsinki and UusimaaFinnish Institute for Health and Welfare; City of Espoo; Ministry of Social Affairs...UnknownDepressive DisorderFinland
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Northwestern UniversityDiabetes Action Research and Education FoundationCompletedDiabetes Mellitus, Type 2 | Diabetes ComplicationsUnited States
-
National Institute of Diabetes and Digestive and...CompletedHypertension | Diabetes Mellitus, Type 2 | HyperlipidemiaUnited States
-
American Academy of Family PhysiciansRobert Wood Johnson Foundation; Agency for Healthcare Research and Quality...CompletedSmoking | Physical Activity | Diet | Alcohol AbuseUnited States
-
German Cancer Research CenterGerman Federal Ministry of Education and Research; Heidelberg UniversityCompletedType 2 Diabetes MellitusGermany